Enoxaparin vs heparin: the 6-month and 1-year SYNERGY results

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1516, 2005-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enoxaparin beats tinzaparin: the 6-month EVET trial results

By  

Inpharma, Vol. 1, Iss. 1509, 2005-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Enoxaparin/eptifibatide vs heparin/eptifibatide: antithrombotic effects

By  

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

SYNERGY: enoxaparin an alternative to heparin in ACS?

By  

Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Enoxaparin versus Heparin: The SYNERGY Trial from an Emergency Medicine Perspective

By Rokos Ivan C.  

Drugs, Vol. 65, Iss. 10, 2005-01 ,pp. : 1313-1316

Adis International

Access to resources Recommend Favorite

Amisulpride vs. Risperidone in Chronic Schizophrenia - Results of a 6-month Double-blind Study

By Sechter D.   Peuskens J.   Fleurot O.   Rein W.   Lecrubier Y.   the   Amisulpride Study Group  

Neuropsychopharmacology, Vol. 27, Iss. 6, 2002-12 ,pp. : 1071-1081

Elsevier

Access to resources Recommend Favorite